Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Trials|January 27, 2019
Efficacy of motivating short interventions for smokers in primary care (COSMOS trial): study protocol for a cluster-RCTThomas Grischott, Oliver Senn, Thomas Rosemann, et al.
Frontiers in Pharmacology|March 3, 2022
Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice-A Cross-Sectional Database StudyYael Rachamin, Levy Jäger, Rahel Meier, et al.
Swiss Medical Weekly|November 21, 2024
Blood pressure control and antihypertensive treatment in Swiss general practice: a cross-sectional study using routine dataStefania Di Gangi, Roman Brenner, Thomas Grischott, et al.
Swiss Medical Weekly|February 20, 2025
Leveraging free-text diagnoses to identify patients with diabetes mellitus, obesity or dyslipidaemia - a cross-sectional study in a large Swiss primary care databaseDonika Balaj, Jakob M Burgstaller, Audrey Wallnöfer, et al.
Swiss Medical Weekly|October 19, 2023
Importance of different electronic medical record components for chronic disease identification in a Swiss primary care database: a cross-sectional studyRahel Meier, Thomas Grischott, Yael Rachamin, et al.
The Lancet. Oncology|May 4, 2020
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost-benefit analysisKerstin N Vokinger, Thomas J Hwang, Thomas Grischott, et al.
European Geriatric Medicine|February 25, 2026
Effectiveness, feasibility, and acceptance of a general practice-based supportive intervention for dementia caregivers: the AD HOC trialGino Bopp, Thomas Grischott, Giuseppe Pichierri, et al.
Vaccine|July 5, 2025
A multifaceted, targeted intervention to improve human papillomavirus vaccination rates in general practice: A pragmatic cluster-randomized controlled trialAndreas Plate, Levy Jäger, Stefania Di Gangi, et al.
Implementation Science : IS|December 29, 2018
Improving inappropriate medication and information transfer at hospital discharge: study protocol for a cluster RCTThomas Grischott, Stefan Zechmann, Yael Rachamin, et al.
JAMA Oncology|July 1, 2021
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and EuropeKerstin N Vokinger, Thomas J Hwang, Paola Daniore, et al.
Pageof 4